Teva Canada Limited v. Bayer Inc.

Teva Canada Limited v. Bayer Inc.

The Court ordered that the reasons for judgment in file A-16-20 shall constitute the reasons for judgment in this appeal (A-15-20).

Source-derived case information.

Citation
2020 FCA 72
Parties
Appellant: Teva Canada Limited; Respondent: Bayer Inc. and Bayer Intellectual Property GmbH; Respondent: Apotex Inc.; Respondent: Taro Pharmaceuticals Inc.; Respondent: Sandoz Canada Inc.
Court
Federal Court of Appeal
Jurisdiction
Canada
Judgment Date
8 April 2020
Procedural Posture
Appeal / Reasons for Judgment Adopted / Judgment Delivered
Outcome
Reasons in file A-16-20 adopted as the reasons for judgment in this appeal.
Legal Topics
Adoption of Reasons From Another File, Procedural Disposition
Source Language
en
Intellectual Property Patent Law Adoption of Reasons From Another File Procedural Disposition

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 2 Party arguments 2
Sign in to unlock

Parties

Teva Canada Limited

Appellant

Bayer Inc. and Bayer Intellectual Property GmbH

Respondent

Apotex Inc.

Respondent

Taro Pharmaceuticals Inc.

Respondent

Sandoz Canada Inc.

Respondent

Procedural Posture

Appeal / Reasons for Judgment Adopted / Judgment Delivered

  1. 1 Whether the Court should adopt the reasons for judgment in file A-16-20 as the reasons in this appeal
  2. 2 Whether any separate disposition was required for this appeal beyond adoption of those reasons

Ratio Decidendi

The Court ordered that the reasons for judgment in file A-16-20 shall constitute the reasons for judgment in this appeal (A-15-20).

Court Disposition

Reasons in file A-16-20 adopted as the reasons for judgment in this appeal.

Orders

  • The attached copy of the reasons for judgment in file A-16-20 shall constitute the reasons for judgment in this appeal.